Variables relating to diet, hormones, and genetic background are major factors in the development of obesity. Moreover, hypothalamic neurotransmitter systems are known to influence food intake, appetite, metabolism, and body weight. In particular, the catecholamine, norepinephrine (NE), has been shown in animals to potentiate food intake in satiated subjects, enhance appetite specifically for carbohydrate, affect circulating hormones and nutrients, and reduce energy expenditure. This neurotransmitter, which produces hyperphagia and increased body weight gain with chronic administration, is found to act via a,-noradTenergic receptors specifically in the hypothalamic paraventricular nucleus (PVN). Circulating substances, such as the glucocorticoid hormone corticosterone (CORT) and glucose, have been shown to influence these PVN a1 receptors, as well as eating Moreover, evidence suggests that this a,-receptor system becomes most active and exerts its maximum physiological effects precisely at the start of active cycle, when circulating CORT levels normally peak and when eating behavior, and in particular carbohydrate preference, is strongest. 1-3
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METHODS
A standard radioligand binding technique, using the a2-noradrenergic receptor agonist ['HI p-aminoclonidine ([3H]PAC; 45.8 Ci/mmol), was employed to determine the a2-receptor density in seven micropunched hypothalamic areas. Nonspecific binding was determined in the presence of phentolamine, and the results are expressed as 13H]PAC specifically bound in fmoles/mg protein.
RESULTS
Experiment 1: a ' Receptors in Relation to Diet-Induced Obesity
The exposure to a high-fat diet for six weeks caused variable changes in body weight in individual rats, ranging from low to severe levels of obesity. Analyses of hypothalamic a2 receptors (FIG. 1) indicated a significant increase in [3H]PAC binding in the PVN of moderate (+ 50%; p < 0.05) and severely (+ 100%; p < 0.001) dietary-induced obese rats, and also in the dorsomedial nucleus of severely obese rats, as compared to dietary-resistant and chow-fed rats (+ 100%; p < 0.01). In contrast, the density of a,-noradrenergic receptors in other hypothalamic areas remained ~n c h a n g e d .~
Experiment 2: a, -Noradrenergic Receptors in Genetically Controlled
Obese and k a n Zucker Rats FIGURE 1 presents the [3] PAC binding results for the PVN of lean and obese Zucker rats. As shown here, genetically obese rats had a significantly greater number of available a,-noradrenergic receptors in the PVN (+ 120%; p < 0.05) than did their lean littermates. Other hypothalamic areas, however, exhibited no group differences in their a,-receptor density.
Experiment 3: a,-Noradrenergic Receptors in Relation to
Circulating Levels of CORT As shown in FIGURE 1, the loss of circulating CORT through adrenalectomy (ADX)
caused a significant decrement (-46%; p < 0.05) in [3] PAC binding to al-noradrenergic receptors, specifically in the PVN., Subcutaneous CORT implants, which raised circulating CORT levels to 14 pg%, totally and significantly reversed the [3] PAC binding in the PVN (p < 0.001). This down regulation of PVN a, receptors in ADX rats, associated with a dramatic decline in eating behavior, was completely reversed by chronic subcutaneous CORT implants, which raised circulating hormone levels to 14 pg% and significantly increased food intake. The only other hypothalamic area affected was the supraoptic nucleus, which exhibited the opposite pattern of changes in az-receptor binding.
CONCLUSION
The results of these studies demonstrate that the a,-noradrenergic receptors specifically in the PVN, which are known to have a role in the control of energy intake and expenditure, exhibit dramatic changes in relation to dietary, genetic, and hormonal factors that are known to contribute to the onset and maintenance of obesity. Further research is needed to establish whether these receptor changes precede or are consequent to the development of hyperphagia and weight gain.
